{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:15:35Z","timestamp":1771539335205,"version":"3.50.1"},"reference-count":77,"publisher":"Informa UK Limited","issue":"9","funder":[{"name":"Celltrion and Pfizer Korea"},{"name":"Abbvie Korea"},{"DOI":"10.13039\/100018592","name":"Celltrion","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018592","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Chong Kun Dang Pharm"},{"name":"Daewoong Pharma"},{"name":"Ferring Korea"},{"name":"IQVIA, Cornerstones Health, Robarts Clinical Trials Inc"},{"name":"Abbvie Korea, Celltrion, Ferring Korea"},{"name":"Pfizer Korea"},{"name":"Shire Korea, Takeda Korea and IQVIA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.2217\/imt-2020-0086","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T06:30:21Z","timestamp":1591770621000},"page":"609-623","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["An Updated Review of Infliximab Biosimilar, CT-P13, in the Treatment of Immune-Mediated Inflammatory Diseases"],"prefix":"10.1080","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-9950","authenticated-orcid":false,"given":"Seung","family":"Wook\u00a0Hong","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8029-7355","authenticated-orcid":false,"given":"Yong-Gil","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6647-6325","authenticated-orcid":false,"given":"Byong Duk","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"},{"name":"Inflammatory Bowel Disease Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.052688"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.18053\/jctres.02.201603.005"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw053"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.10.67"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0233-1"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13295"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)05246-0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011303432202"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21678"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20852"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.02.021"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67566-6"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20967"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032268"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710093371502"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199905063401804"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030815"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.003"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"e_1_3_4_23_1","unstructured":"European Medicines Agency . Committee for medicinal products for human use (CHMP). Assessment report: remsima (infliximab) (2013). www.ema.europa.eu\/en\/documents\/assessment-report\/remsima-epar-public-assessment-report_en-0.pdf"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.32221"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.6b04436"},{"key":"e_1_3_4_26_1","unstructured":"World Health Organization . Expert Committee on Biological Standardization. Guidelines on evaluation of similar biotherapeutic products (SBPs). (2009). www.who.int\/biologicals\/areas\/biological_therapeutics\/BIOTHERAPEUTICS_FOR_WEB_22APRIL2010.pdf"},{"key":"e_1_3_4_27_1","unstructured":"European Medicines Agency . Guideline on similar biological medicinal products. (2014). www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-similar-biological-medicinal-products-first-version_en.pdf"},{"key":"e_1_3_4_28_1","unstructured":"US Food and Drugs Administration . Scientific considerations in demonstrating biosimilarity to a reference product. (2015). www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/scientific-considerations-demonstrating-biosimilarity-reference-product"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-014-0094-1"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1090310"},{"key":"e_1_3_4_31_1","unstructured":"European Medicines Agency . Committee for Medicinal Products for Human Use (CHMP). Assessment report: inflectra. (2013). www.ema.europa.eu\/en\/documents\/assessment-report\/inflectra-epar-public-assessment-report_en.pdf"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-06-583617"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1090311"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203090"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0981-6"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203091"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-0930-4"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208786"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208783"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-425744"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/327120"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2014.05.005"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-013-9534-y"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11938-018-0177-z"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.05.023"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12432"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1159\/000449089"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725-199811000-00014"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.7.7.1051"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.105379"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32196-2"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12880"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S124975"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.002"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15659"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15755"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2015.1064893"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091308"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12997"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-014-3392-z"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1091309"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv220"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2016.1149883"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv233"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1512"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz070"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw085"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001237"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14645"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2018.1512406"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-017-0219-4"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309290"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-014-0595-3"},{"key":"e_1_3_4_75_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.2015.1067142"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00322"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"e_1_3_4_78_1","unstructured":"BSG . BSG guidance on the use of biosimilar infliximab CT-P13 in inflammatory bowel disease. (2016). https:\/\/www.bsg.org.uk\/wp-content\/uploads\/2019\/12\/BSG-Guidance-on-the-Use-of-Biosimilar-Infliximab-CT-P13-in-IBD.pdf"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw198"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt-2020-0086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T20:39:55Z","timestamp":1715978395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt-2020-0086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":77,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.2217\/imt-2020-0086"],"URL":"https:\/\/doi.org\/10.2217\/imt-2020-0086","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iimy20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-04-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}